Medical Condition News

RSS

Stent graft can repair abdominal aortic aneurysm

When Dr. Ross Milner repaired Lydia Strebing's life-threatening abdominal aortic aneurysm, she was astonished at how easy it was. "I've had more pain from dental procedures," she said. "This was nothing." Milner, chief of vascular surgery at Loyola University Hospital, repaired the bulging aneurysm by using a catheter to deploy a device called a stent graft.

8 Jun 2011

Low phosphate intake can reduce heart disease

Lowering phosphate intake in humans can reduce heart disease, according to research by experts at the University of Sheffield.

8 Jun 2011

FDA approves Mylan's ANDA for Donepezil HCl Tablets to treat dementia linked with Alzheimer's

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Donepezil Hydrochloride (HCl) Tablets, 5 mg and 10 mg, the generic version of Eisai's Aricept Tablets, which are used to treat dementia associated with Alzheimer's disease.

8 Jun 2011

$Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS$

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.

8 Jun 2011

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

7 Jun 2011

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced clinical and preclinical data from its lead program, KAI-4169, at the Endocrine Society's 93rd Annual Meeting (ENDO 2011) taking place in Boston, June 4-7, 2011. KAI-4169 is a novel pharmaceutical agent being developed for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

7 Jun 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.

7 Jun 2011

LLS announces four new Academic Concierge partnerships for cancer drug development

With more than 320 academic science research grants currently in its portfolio, The Leukemia & Lymphoma Society (LLS) has made it a priority to help move promising discoveries more quickly from the laboratory to clinical trial and to patients with cancer.

7 Jun 2011

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of the human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.

7 Jun 2011

Merck, Roche partner to develop cancer diagnostic assays

Merck, known outside the United States and Canada as MSD, and Roche today announced that they have entered into a collaboration focused on the application and development of diagnostic assays for use with Merck's investigational cancer therapy portfolio.

From Roche Sequencing and Life Science 7 Jun 2011

IsoRay completes Iotrex license agreement with Dr. Reddy's

IsoRay, Inc. announced today that it has completed a license agreement with Dr. Reddy's Laboratories for exclusive worldwide licensing rights to Iotrex, a liquid iodine radiation, for use in brain cancer treatment.

7 Jun 2011

LUMEDX releases new Webinar, The Power of Analytics: Managing Cath Lab Growth in Real Time

LUMEDX Corporation, a leading provider of integrated cardiovascular information systems (CVIS), today announced the release of a new and complimentary educational Webinar on CD, The Power of Analytics: Managing Cath Lab Growth in Real Time.

7 Jun 2011

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

OncoSec Medical Incorporated, which is developing its advanced-stage ElectroOncology therapies to treat solid tumor cancers, announced today that additional evaluation of a previous Phase I trial provided further evidence that a DNA plasmid encoded to produce IL-12 delivered by electroporation into melanoma lesions induces responses to known and novel antigens, resulting in regression of local treated lesions as well as distant untreated lesions.

7 Jun 2011

Key heart failure therapies could prevent nearly 68,000 deaths each year

A national study has found that nearly 68,000 deaths potentially could be prevented each year by optimally implementing key national guideline-recommended therapies, including critical medications and cardiac devices, for all eligible heart failure patients.

7 Jun 2011

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

The 26th Annual Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 9-12, 2011, at the Gaylord National Hotel & Convention Center, National Harbor, MD.

7 Jun 2011

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure.

7 Jun 2011

Novel technique promises to reduce damage after heart attack

Scientists at the University of Leicester are investigating a novel technique that promises to protect heart muscle from life-threatening damage following a heart attack - simply by squeezing an arm. Heart attacks are the major cause of premature death in England, with massive implications for survival and costs of long-term health care.

7 Jun 2011

Study provides epidemiology of fatal occupational traumatic brain injury in the U.S.

Although traumatic brain injury (TBI) is one of the leading causes of death in the United States, work-related TBI has not been well documented. In a study published in the July issue of the American Journal of Preventive Medicine, researchers describe the epidemiology of fatal TBI in the US workplace between 2003 and 2008.

7 Jun 2011

$Zoledronate at lower dose effective in reducing risk of osteoporotic fractures$

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

A lower dose of zoledronic acid than currently recommended for prevention of bone fractures due to osteoporosis decreases bone resorption and increases bone density, and may be effective in reducing the risk of osteoporotic fractures, a study finds.

7 Jun 2011

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

Halozyme Therapeutics, Inc. and Intrexon Corporation, today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous injectable formulation of Intrexon Corporation's recombinant human alpha 1-antitrypsin (rHuA1AT).

7 Jun 2011

Medical Condition News

Stent graft can repair abdominal aortic aneurysm

Low phosphate intake can reduce heart disease

FDA approves Mylan's ANDA for Donepezil HCl Tablets to treat dementia linked with Alzheimer's

Telik initiates Telintra Phase 2 trial in Revlimid refractory or resistant, del 5q MDS

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Promising results from KAI-4169 program for CKD-MBD presented at ENDO 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

LLS announces four new Academic Concierge partnerships for cancer drug development

Geron's GRNOPC1 Phase 1 trial results on spinal cord injury presented at international conferences

Merck, Roche partner to develop cancer diagnostic assays

IsoRay completes Iotrex license agreement with Dr. Reddy's

LUMEDX releases new Webinar, The Power of Analytics: Managing Cath Lab Growth in Real Time

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

Key heart failure therapies could prevent nearly 68,000 deaths each year

LWW sponsors 26th Annual Clinical Symposium on Advances in Skin & Wound Care

Study explores link between hospital procedure volume, surgical outcomes after joint replacements

Novel technique promises to reduce damage after heart attack

Study provides epidemiology of fatal occupational traumatic brain injury in the U.S.

Zoledronate at lower dose effective in reducing risk of osteoporotic fractures

Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News